Table 5 Haematological variables (mean ± SD)
From: Lifestyle exercise attenuates immunosenescence; flow cytometry analysis
|  | Reference values | Active n = 34 | Inactive n = 20 | Active vs. Inactive p level | η2 |
|---|---|---|---|---|---|
WBC [103/μL] | 5.0–11.6 | 6.7 ± 2.1 | 6.5 ± 2.0 | 0.740 | 0.055 |
Lymphocytes [103/μL] | 1.3–4.0 | 2.3 ± 0.6 | 2.2 ± 0.9 | 0.119 | 0.002 |
Granulocytes [103/μL] | 2.4–7.6 | 3.9 ± 1.6 | 3.8 ± 1.4 | 0.851 | 0.076 |
LYM % | 19.1–48.5 | 35.5 ± 7.6 | 33.7 ± 9.0 | 0.486 | 0.003 |
GRA % | 43.6–73.4 | 57.2 ± 9.2 | 57.2 ± 9.0 | 0.981 | 0.000 |
RBC [103/μL] | F 4.0–5.5 M 4.5–6.6 | 4.8 ± 0.3 | 4.7 ± 0.3 | 0.209 | 0.054 |
HB [g/dL] | F 12.5–16.0 M 13.5–18.0 | 13.9 ± 0.7 | 13.7 ± 0.8 | 0.513 | 0.108 |
HCT [%] | F 37–47 M 40.0–51.0 | 39.5 ± 2.0 | 38.6 ± 2.4 | 0.201 | 0.031 |
MCV [fL] | F 80–95 M 80–97 | 81.9 ± 3.0 | 81.7 ± 2.6 | 0.950 | 0.048 |
MCH [pg] | F 27.0–32.0 M 26.0–32.0 | 28.7 ± 1.3 | 29.0 ± 1.1 | 0.395 | 0.054 |
MCHC [g/dL] | F 32.0–36.0 M 31.0–36.0 | 35.1 ± 0.8 | 35.5 ± 0.6 | 0.330 | 0.018 |
PLT [103/μL] | 150–400 | 270 ± 60 | 236 ± 39 | < 0.01 | 0.031 |